Analyzing How Genetics May Affect Response to High Blood Pressure Medications

CompletedOBSERVATIONAL
Enrollment

37,939

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
HypertensionCoronary DiseaseCerebrovascular Accident
Trial Locations (2)

55455

University of Minnesota, Minneapolis

77030

University of Texas Houston, Houston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University of Texas

OTHER

collaborator

University of Minnesota

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT00563901 - Analyzing How Genetics May Affect Response to High Blood Pressure Medications | Biotech Hunter | Biotech Hunter